Effect of bisoprolol on respiratory function and exercise capacity in chronic obstructive pulmonary disease

American Journal of Cardiology

Volumn 110, Issue 2, 2012, Pages 258-263

  Mainguy, Vincent ^a   Girard, Daniel ^a   Maltais, François ^a   Saey, Didier ^a   Milot, Julie ^a   Sénéchal, Mario ^a   Poirier, Paul ^a   Provencher, Steeve ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BISOPROLOL; PLACEBO;

AGED; BLOOD PRESSURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFECT; ECHOCARDIOGRAPHY; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HEART RATE; HUMAN; HYPERINFLATION; INSPIRATORY CAPACITY; LUNG FUNCTION TEST; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FUNCTION; TREATMENT DURATION;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; AGED; BISOPROLOL; BLOOD PRESSURE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART RATE; HUMANS; INSPIRATORY CAPACITY; MALE; OXYGEN CONSUMPTION; PHYSICAL ENDURANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84862766531     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.03.019     Document Type: Conference Paper

References (28)

1. J. Mascarenhas, P. Lourenco, R. Lopes, A. Azevedo, P. Bettencourt Chronic obstructive pulmonary disease in heart failure Prevalence, therapeutic and prognostic implications Am Heart J 155 2008 521 525
2. S. Viskin, H.V. Barron Beta blockers prevent cardiac death following a myocardial infarction: so why are so many infarct survivors discharged without beta blockers? Am J Cardiol 78 1996 821 822
3. M. Komajda, F. Follath, K. Swedberg, J. Cleland, J.C. Aguilar, A. Cohen-Solal, R. Dietz, A. Gavazzi, W.H. Van Gilst, R. Hobbs, J. Korewicki, H.C. Madeira, V.S. Moiseyev, I. Preda, J. Widimsky, N. Freemantle, J. Eastaugh, J. Mason The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe Part 2: treatment Eur Heart J 24 2003 464 474
4. S. Salpeter, T. Ormiston, E. Salpeter Cardioselective beta-blockers for chronic obstructive pulmonary disease Cochrane Database Syst Rev 2005 CD003566
5. J.R. Enriquez, S.V. Parikh, F. Selzer, A.K. Jacobs, O. Marroquin, S. Mulukutla, V. Srinivas, E.M. Holper Increased adverse events after percutaneous coronary intervention in patients with COPD: insights from the National Heart, Lung, and Blood Institute dynamic registry Chest 140 2011 604 610
6. D.E. O'Donnell Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease Proc Am Thorac Soc 3 2006 180 184
7. D.E. O'Donnell, T. Fluge, F. Gerken, A. Hamilton, K. Webb, B. Aguilaniu, B. Make, H. Magnussen Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD Eur Respir J 23 2004 832 840
8. D.E. O'Donnell, S. Aaron, J. Bourbeau, P. Hernandez, D.D. Marciniuk, M. Balter, G. Ford, A. Gervais, R. Goldstein, R. Hodder, A. Kaplan, S. Keenan, Y. Lacasse, F. Maltais, J. Road, G. Rocker, D. Sin, T. Sinuff, N. Voduc Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update Can Respir J 14 suppl 2007 5B 32B
9. N. Macintyre, R.O. Crapo, G. Viegi, D.C. Johnson, C.P. van der Grinten, V. Brusasco, F. Burgos, R. Casaburi, A. Coates, P. Enright, P. Gustafsson, J. Hankinson, R. Jensen, R. McKay, M.R. Miller, D. Navajas, O.F. Pedersen, R. Pellegrino, J. Wanger Standardisation of the single-breath determination of carbon monoxide uptake in the lung Eur Respir J 26 2005 720 735
10. M.R. Miller, J. Hankinson, V. Brusasco, F. Burgos, R. Casaburi, A. Coates, R. Crapo, P. Enright, C.P. van der Grinten, P. Gustafsson, R. Jensen, D.C. Johnson, N. MacIntyre, R. McKay, D. Navajas, O.F. Pedersen, R. Pellegrino, G. Viegi, J. Wanger Standardisation of spirometry Eur Respir J 26 2005 319 338
11. J. Wanger, J.L. Clausen, A. Coates, O.F. Pedersen, V. Brusasco, F. Burgos, R. Casaburi, R. Crapo, P. Enright, C.P. van der Grinten, P. Gustafsson, J. Hankinson, R. Jensen, D. Johnson, N. Macintyre, R. McKay, M.R. Miller, D. Navajas, R. Pellegrino, G. Viegi Standardisation of the measurement of lung volumes Eur Respir J 26 2005 511 522
12. R. Pellegrino, G. Viegi, V. Brusasco, R.O. Crapo, F. Burgos, R. Casaburi, A. Coates, C.P. van der Grinten, P. Gustafsson, J. Hankinson, R. Jensen, D.C. Johnson, N. MacIntyre, R. McKay, M.R. Miller, D. Navajas, O.F. Pedersen, J. Wanger Interpretative strategies for lung function tests Eur Respir J 26 2005 948 968
13. B.M. McQuillan, M.H. Picard, M. Leavitt, A.E. Weyman Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects Circulation 104 2001 2797 2802
14. ATS/ACCP statement on cardiopulmonary exercise testing Am J Respir Crit Care Med 167 2003 211 277
15. D.G. Stubbing, L.D. Pengelly, J.L. Morse, N.L. Jones Pulmonary mechanics during exercise in subjects with chronic airflow obstruction J Appl Physiol 49 1980 511 515
16. G.A. Borg Psychophysical bases of perceived exertion Med Sci Sports Exerc 14 1982 377 381
17. D.E. O'Donnell, N. Voduc, M. Fitzpatrick, K.A. Webb Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease Eur Respir J 24 2004 86 94
18. R. Casaburi Factors determining constant work rate exercise tolerance in COPD and their role in dictating the minimal clinically important difference in response to interventions COPD 2 2005 131 136
19. N.M. Hawkins, M.C. Petrie, M.R. MacDonald, P.S. Jhund, L.M. Fabbri, J. Wikstrand, J.V. McMurray Heart failure and chronic obstructive pulmonary disease: the quandary of beta-blockers and beta-agonists J Am Coll Cardiol 57 2011 2127 2128
20. N.M. Hawkins, M.R. MacDonald, M.C. Petrie, G.W. Chalmers, R. Carter, F.G. Dunn, J.J. McMurray Bisoprolol in patients with heart failure and moderate to severe chronic obstructive pulmonary disease: a randomized controlled trial Eur J Heart Fail 11 2009 684 690
21. D.E. O'Donnell, J. Travers, K.A. Webb, Z. He, Y.M. Lam, A. Hamilton, S. Kesten, F. Maltais, H. Magnussen Reliability of ventilatory parameters during cycle ergometry in multicentre trials in COPD Eur Respir J 34 2009 866 874
22. S. Provencher, P. Herve, X. Jais, D. Lebrec, M. Humbert, G. Simonneau, O. Sitbon Deleterious effects of beta-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension Gastroenterology 130 2006 120 126
23. L. Huiart, P. Ernst, S. Suissa Cardiovascular morbidity and mortality in COPD Chest 128 2005 2640 2646
24. D.D. Sin, S.F. Man Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease Circulation 107 2003 1514 1519
25. K. Marquis, F. Maltais, V. Duguay, A.M. Bezeau, P. LeBlanc, J. Jobin, P. Poirier The metabolic syndrome in patients with chronic obstructive pulmonary disease J Cardiopulm Rehabil 25 2005 226 232
26. D.H. Au, E.M. Udris, V.S. Fan, J.R. Curtis, M.B. McDonell, S.D. Fihn Risk of mortality and heart failure exacerbations associated with inhaled beta-adrenoceptor agonists among patients with known left ventricular systolic dysfunction Chest 123 2003 1964 1969
27. T. Simon, M. Mary-Krause, C. Funck-Brentano, P. Lechat, P. Jaillon Bisoprolol dose-response relationship in patients with congestive heart failure: a subgroup analysis in the Cardiac Insufficiency Bisoprolol Study (CIBIS II) Eur Heart J 24 2003 552 559
28. G. Leopold Balanced pharmacokinetics and metabolism of bisoprolol J Cardiovasc Pharmacol 8 suppl 1986 S16 S20